AstraZeneca Launches Targeted Lung Cancer Drug in U.S.
WILMINGTON, DE — AstraZeneca has launched ZEGFROVY (sunvozertinib) in the United States for adults with a specific form of advanced lung cancer that has progressed following platinum-based chemotherapy, expanding access …
AstraZeneca Launches Targeted Lung Cancer Drug in U.S. Read More